- Health
- Medicine
- Research
Ph I Study of IGM-8444 as a Single Agent & in Combo in Subjects w/ Relapsed &/or Refr Solid Cancers
Warren A Chow
A Study On:
- Other
Status:
- Open
Eligibility
Adult
Interested in joining this trial?
Official Title
An Open-Label, Multicenter, Phase I Study of IGM-8444 as a Single Agent and in Combination in Subjects with Relapsed and/or Refractory Solid Cancers
Eligibility
You can join if...
You can participate in this study if you are at least 18 years of age or older; have been clinically diagnosed with of locally advanced or metastatic cancer. You cannot participate in this study if you are pregnant or breast feeding; if you are using medication well known to cause liver toxicity.Get in touch with our study team
News & Events
- Community
- Faculty
- Health
- Faculty
- Health
- In the News